Monocyte-and endothelial-derived microparticles induce an inflammatory phenotype in human podocytes

Nephron - Experimental Nephrology

Volumn 119, Issue 3, 2011, Pages

  Eyre, Jeanette ^a   Burton, James O ^a,b   Saleem, Moin A ^c   Mathieson, Peter W ^c   Topham, Peter S ^a,b   Brunskill, Nigel J ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Albumin; Glomerular inflammation; IL 6; MCP 1; Microparticles; Podocyte; Proteinuria; VEGF

Indexed keywords

ALBUMIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ALBUMINOID; ANGIOPOIETIN 2; AUTACOID; CCL2 PROTEIN, RAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ARTICLE; BLOOD VESSEL INJURY; CELL FUNCTION; CELL STRAIN U937; CONTROLLED STUDY; DISEASE COURSE; ELECTRON MICROSCOPY; ENDOCYTOSIS; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; KIDNEY DISEASE; MEMBRANE MICROPARTICLE; MONOCYTE; MONOLAYER CULTURE; NEPHRITIS; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEINURIA; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; CELL CULTURE; ENDOTHELIUM CELL; GLOMERULONEPHRITIS; INFLAMMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; U937 CELL LINE;

ALBUMINS; ANGIOPOIETIN-2; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIAL CELLS; GLOMERULONEPHRITIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MICROSCOPY, ELECTRON, TRANSMISSION; MONOCYTES; PHENOTYPE; PODOCYTES; PROTEINURIA; U937 CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 80051621508     PISSN: 16602129     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000329575     Document Type: Article

References (34)

1. Hillege HL, Fidler V, Diercks GFH, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans ROB, Janssen WMT, Grobbee DE, de Jong PE, Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study Group: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
2. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL: Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 1995; 123: 754-762.
3. Pavenstadt H, Kriz W, Kretzler M: Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307. (Pubitemid 36459882)
4. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ: Membranederived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20: 1487-1495. (Pubitemid 44264090)
5. Piccin A, Murphy WG, Smith OP: Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007; 21: 157-171. (Pubitemid 46529055)
6. Jan S, Monique PG: Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006; 20: 1-26.
7. Arteaga RB, Chirinos JA, Soriano AO, Jy W, Horstman L, Jimenez JJ, Mendez A, Ferreira A, Marchena ED, Ahn YS: Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 2006; 98: 70-74. (Pubitemid 43902682)
8. Preston RA, Jy W, Jimenez JJ, Mauro LM, Horstman LL, Valle M, Aime G, Ahn YS: Effects of severe hypertension on endothelial and platelet microparticles. Hypertension 2003; 41: 211-217. (Pubitemid 36204891)
9. Boulanger CM, Amabile N, Guerin AP, Pannier B, Leroyer AS, Mallat CN, Tedgui A, London GM: In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension 2007; 49: 902-908. (Pubitemid 351664206)
10. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost 2006; 4: 566-573.
11. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R: Microparticles in cardiovascular diseases. Cardiovasc Res 2003; 59: 277-287. (Pubitemid 37272022)
12. Davis JS, Lie JT: Extracellular glomerular microparticles in nephrotic syndrome of heroin users. Arch Pathol 1975; 99: 278-282.
13. Kimura M, Sato I, Shiratori Y, Sugawara N, Ozawa K, Yamabe H: Electron microscopic studies on IgA nephropathy. Acta Pathol Jpn 1984; 34: 289-304. (Pubitemid 14102827)
14. Terasaki T, Sano M, Narita M, Tojo S: Ultrastructural study of gaps of the glomerular basement membrane in IgA nephropathy. Am J Nephrol 1986; 6: 443-449. (Pubitemid 17014766)
15. Shirota K, Tanaka H, Sugimoto J, Nomura Y: Alteration of anionic sites in renal glomerular basement membrane of pigs. J Vet Med Sci 1997; 59: 857-862. (Pubitemid 127524316)
16. Pisitkun T, Shen RF, Knepper MA: Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004; 101: 13368-13373. (Pubitemid 39209672)
17. Hara M, Yanagihara T, Kihara I, Higashi K, Fujimoto K, Kajita T: Apical cell membranes are shed into urine from injured podocytes: a novel phenomenon of podocyte injury. J Am Soc Nephrol 2005; 16: 408-416. (Pubitemid 41725136)
18. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M: The human urinary proteome contains more than 1,500 proteins, including a large proportion of membrane proteins. Genome Biol 2006; 7:R80.
19. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13: 630-638. (Pubitemid 34183927)
20. Eyre J, Ioannou K, Grubb BD, Saleem MA, Mathieson PW, Brunskill NJ, Christensen EI, Topham PS: Statin-sensitive endocytosis of albumin by glomerular podocytes. Am J Physiol Renal Physiol 2007; 292:F674-F681. (Pubitemid 46220536)
21. Jaffe EA, Nachman RL, Becker CG, Minick CR: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756.
22. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F, Mutin M, Sanmarco M, Sampol J, Dignat-George F: In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102. (Pubitemid 29534349)
23. Satchell SC, Tasman CH, Singh A, Ni L, Geelen J, von Ruhland CJ, O'Hare MJ, Saleem MA, van den Heuvel LP, Mathieson PW: Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 2006; 69: 1633-1640.
24. Hirschberg R, Wang S, Mitu G: Functional symbiosis between endothelium and epithelial cells in glomeruli. Cell Tissue Res 2008; 331: 485-493.
25. Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA: Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005; 106: 1604-1611. (Pubitemid 41208572)
26. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C: Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005; 25: 1512-1518. (Pubitemid 40923377)
27. Obregon C, Rothen-Rutishauser B, Gitahi SK, Gehr P, Nicod LP: Exovesicles from human activated dendritic cells fuse with resting dendritic cells, allowing them to present alloantigens. Am J Pathol 2006; 169: 2127-2136. (Pubitemid 351181972)
28. Whale TA, Wilson HL, Tikoo SK, Babiuk LA, Griebel PJ: Pivotal advance: passively acquired membrane proteins alter the functional capacity of bovine polymorphonuclear cells. Leukoc Biol 2006; 80: 481-491. (Pubitemid 44835781)
29. Jin M, Drwal G, Bourgeois T, Saltz J, Haifeng M: Distinct proteome features of plasma microparticles. Proteomics 2005; 5: 1950-1952.
30. Duits AJ, Dimjati W, van de Winkel JG, Capel PJ: Synergism of interleukin-6 and 1.4,25-dihydroxyvitamin D 3 in induction of myeloid differentiation of human leukemic cell lines. J Leukoc Biol 1992; 51: 237-243.
31. Eremina V, Baelde HJ, Quaggin SE: Role of the VEGF-a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier. Nephron Physiol 2007; 106: 32-37.
32. Eremina V, Sood M, Haigh J, Nagy A, Lajoie G, Ferrara N, Gerber HP, Kikkawa Y, Miner JH, Quaggin SE: Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707-716. (Pubitemid 36278589)
33. Woolf AS, Gnudi L, Long DA: Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 2009; 20: 239-244.
34. Davis B, Dei Cas A, Long DA, White KE, Hayward A, Ku CH, Woolf AS, Bilous R, Viberti G, Gnudi L: Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J Am Soc Nephrol 2007; 18: 2320-2329. (Pubitemid 47203848)